Management ChangeJul 15, 2026, 04:32 PM
Jin Medical Appoints Ning Xue as Independent Director
AI Summary
Jin Medical International Ltd. announced the resignation of Dr. Jiayuan (James) Tong as an independent director, effective July 9, 2026. Dr. Tong also stepped down from his committee roles, including Chairperson of the Nominating and Corporate Governance Committee. The company subsequently appointed Mr. Ning Xue as an independent director, effective July 14, 2026, to fill the vacancy. Mr. Xue will assume Dr. Tong's committee positions and will receive US$14,082 for his service during his initial term.
Key Highlights
- Dr. Jiayuan (James) Tong resigned as independent director, effective July 9, 2026.
- Dr. Tong also resigned from the Audit, Compensation, and Nominating and Corporate Governance Committees.
- Mr. Ning Xue appointed as independent director, effective July 14, 2026.
- Mr. Xue will serve as Chairperson of the Nominating and Corporate Governance Committee and a member of the Audit and Compensation Committees.
- Mr. Xue will receive US$14,082 for his service during the initial term ending March 27, 2027.
- Mr. Xue satisfies Nasdaq independence requirements for directors and Audit Committee members.
- Mr. Xue previously served as an independent director of TIAN RUIXIANG Holdings Ltd. from January 2025 to January 2026.
Price Impact
More from ZJYL